Stay updated on BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer

Sign up to get notified when there's something new on the BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer page.
Latest website image capture
Clouds background image

Latest updates to the BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now displays revision v3.5.3, indicating an updated build of the site. This change does not modify study details or functionality.
    Difference
    0.0%
    Check dated 2026-04-30T17:31:35.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision tag updated to v3.5.2 and the previous v3.5.0 tag was removed.
    Difference
    0.0%
    Check dated 2026-04-16T10:15:45.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-25T20:24:56.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Updated the page revision to v3.4.3; the previous revision v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-11T16:53:11.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added and the prior 3.4.1 notice has been removed.
    Difference
    0.3%
    Check dated 2026-02-11T05:09:21.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding was added, stating information may not be up-to-date and that operations may be affected, and the page revision updated from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T04:44:56.000Z thumbnail image

Stay in the know with updates to BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer

Enter your email address, and we'll notify you when there's something new on the BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer page.